In drug discovery, building complex molecules quickly is the name of the game.

A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet ...

Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to ...

The partnership will connect Evogene’s AI-based ChemPass AI with the BCDD’s laboratory infrastructure.

CoCoGraph: A Leap Forward for Molecular Innovation For decades, the discovery of new molecules has often been a slow and ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse ...

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

The deal could include further milestone payments, potentially bringing the total value to approximately $600m.

Takeda will pay Insilico to use its proprietary Pharma.AI platform to advance drug candidates across several therapeutic ...

AI is becoming more capable, but its value still depends on the data, questions and decisions behind it. Where is it ...

ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies reached out to talk. “It was like we ...